Andrew Gengos's Net Worth
Estimate Recalculated Nov 1, 2024 11:30AM EST
Who is Andrew Gengos
Andrew Gengos does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Cyteir Therapeutics, Inc., SYNLOGIC, INC., ImmunoCellular Therapeutics, Ltd., and Athira Pharma, Inc..
SEC CIK
Andrew Gengos's CIK is 0001563623
Past Insider Trading and Trends
2023 was Andrew Gengos's most active year for acquiring shares with 12 total transactions. Andrew Gengos's most active month to acquire stocks was the month of May. 2024 was Andrew Gengos's most active year for disposing of shares, totalling 2 transactions. Andrew Gengos's most active month to dispose stocks was the month of December. 2023 saw Andrew Gengos paying a total of $243,017.22 for 485,012 shares, this is the most they've acquired in one year. In 2016 Andrew Gengos cashed out on 3,284 shares for a total of $6,732.20, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
